Supplement
Cocoa extract is a concentrated source of cacao flavanols, plant compounds that help blood vessel walls make nitric oxide so the vessels relax and widen. Most people look at it for high blood pressure, where the evidence is strong and a Cochrane review found pressure came down. Beyond that the evidence is thinner, and one small study of 20 people found no clear difference in adiponectin.
Sources: PMID 22301923
- Updated
- How we grade
- 56 studies cited
- Best evidence
- Grade B
- Conditions studied
- 26
- Outcomes
- 269
- Graded outcomes
- 011112
Evidence by condition
- Strong
- Moderate
- Limited
- Very limited
Cirrhosis
- Blood Pressure: improves
- Heart Rate: improves
- Hepatic Venous Pressure Gradient: improves
Eye Health
- Blood Pressure: improves
- Intraocular Pressure: improves
General Cardiovascular Health
- Adrenaline: worsens
- Adiponectin
- High-density lipoprotein (HDL): improves
Skin Health
- Blood Flow: improves
- Skin Dryness: improves
- Photoprotection: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood Flow Moderate Increase | Improves (the measure goes up) | Moderate effect | 2 studies | 24 people | ||
| Skin Dryness | Improves (the measure goes up) | 2 studies | 141 people | |||
| Photoprotection | Improves (the measure goes up) | 141 people | ||||
| Skin Elasticity | Improves (the measure goes up) | 117 people | ||||
Type 2 Diabetes
- Blood Flow: improves
- High-density lipoprotein (HDL): improves
- Blood Pressure: improves
Peripheral Arterial Disease
- Blood Flow: improves
- Oxidative Stress Biomarkers: improves
- Peripheral Vascular Disease Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood Flow Moderate Increase | Improves (the measure goes up) | Moderate effect | 2 studies | 43 people | ||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 2 studies | 22 people | |||
Studies that measured oxidative stress biomarkers | ||||||
| Peripheral Vascular Disease Symptoms | Improves (the measure goes down) | 2 studies | 43 people | |||
Studies that measured peripheral vascular disease symptoms | ||||||
| Nitric Oxide | Improves (the measure goes up) | 43 people | ||||
Weight Loss & Maintenance
- Blood Flow: improves
- High-density lipoprotein (HDL): improves
- Blood Pressure: improves
Stress
- Adrenaline: worsens
- Blood Viscosity: improves
- Noradrenaline: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Adrenaline Small Decrease | Worsens (the measure goes down) | Small effect | 2 studies | 65 people | ||
| Blood Viscosity | Improves (the measure goes up) | 65 people | ||||
| Noradrenaline | Improves (the measure goes up) | 65 people | ||||
Cardiovascular Disease
- All-Cause Mortality: improves
- High-density lipoprotein (HDL): improves
- Blood Pressure: improves
Overweight
- Arterial Stiffness: improves
- High-density lipoprotein (HDL): improves
- Blood Pressure: improves
Metabolic Syndrome
- High-density lipoprotein (HDL)
- Triglycerides: improves
- Oxidative Stress Biomarkers: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| High-density lipoprotein (HDL) No effect | NoneNo effect | 13 studies | 23 people | |||
| Triglycerides | Improves (the measure goes down) | 3 studies | 23 people | |||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 2 studies | 23 people | |||
| LDL Oxidation | Improves (the measure goes down) | 23 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 23 people | ||||
| Total cholesterol | Improves (the measure goes down) | 23 people | ||||
| vLDL-C | Improves (the measure goes down) | 23 people |
Cognitive Improvement
- Attention
- Blood Pressure: improves
- C-Reactive Protein (CRP): improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Attention No effect | NoneNo effect | 2 studies | 178 people | |||
| Blood Pressure | Improves (the measure goes down) | 10 studies | 90 people | |||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 1 study | 90 people | |||
| Cerebral Blood Flow | Improves (the measure goes up) | 16 people | ||||
| Cerebral Oxygenation | Improves (the measure goes up) | 16 people | ||||
| Cognition | Improves (the measure goes up) | 90 people | ||||
| Fatigue Symptoms | Improves (the measure goes down) | 16 people | ||||
| Memory | Improves (the measure goes up) | 162 people | ||||
| Stress Signs and Symptoms | Improves (the measure goes down) | 72 people | ||||
| Subjective Well-Being | Improves (the measure goes up) | 162 people | ||||
| Working Memory | Improves (the measure goes up) | 162 people |
Mood Improvement
- Attention
- Memory: improves
- Stress Signs and Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Attention No effect | NoneNo effect | 2 studies | 72 people | |||
| Memory | Improves (the measure goes up) | 72 people | ||||
| Stress Signs and Symptoms | Improves (the measure goes down) | 72 people | ||||
| Subjective Well-Being | Improves (the measure goes up) | 72 people | ||||
| Working Memory | Improves (the measure goes up) | 72 people |
Heart Failure
- Heart Failure Risk
- Mitochondrial Protection: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Heart Failure Risk No effect | NoneNo effect | 1 study | 106,109 people | |||
| Mitochondrial Protection | Improves (the measure goes up) | 1 study | 5 people |
Coronary Artery Disease (CAD)
- C-Reactive Protein (CRP)
- High-density lipoprotein (HDL): improves
- Platelet Aggregation: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| C-Reactive Protein (CRP) No effect | NoneNo effect | 1 study | 28 people | |||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 13 studies | 28 people | |||
| Platelet Aggregation | Changes; see studies | 2 studies | 28 people | |||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 28 people |
Metabolic Health
- Adiponectin
- High-density lipoprotein (HDL): improves
- Blood Pressure: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Adiponectin No effect | NoneNo effect | 20 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 13 studies | 439 people | |||
| Blood Pressure | Improves (the measure goes down) | 10 studies | 253 people | |||
| Blood glucose | Improves (the measure goes down) | 5 studies | 61 people | |||
| Triglycerides | Improves (the measure goes down) | 3 studies | 439 people | |||
| Blood Flow | Improves (the measure goes up) | 2 studies | 100 people | |||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 2 studies | 76 people | |||
| Platelet Aggregation | Changes; see studies | 2 studies | 148 people | |||
| Blood Lactate (Exercise) | Changes; see studies | 1 study | 14 people | |||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 1 study | 41 people | |||
| Fat Oxidation | Improves (the measure goes up) | 1 study | 83 people | |||
| Adrenocorticotropic Hormone | Improves (the measure goes up) | 34 people | ||||
| Aerobic Exercise Metrics | Improves (the measure goes up) | 28 people | ||||
| Anaerobic Capacity | Improves (the measure goes up) | 14 people | ||||
| Cell Adhesion Factors | Improves (the measure goes down) | 20 people | ||||
| Cortisol | Improves (the measure goes down) | 34 people | ||||
| Exercise-Induced Oxidation | Changes; see studies | 34 people | ||||
| Glucagon | Changes; see studies | 20 people | ||||
| Glycemic Control | Improves (the measure goes up) | 115 people | ||||
| Heart Rate | Improves (the measure goes down) | 98 people | ||||
| Homocysteine | Improves (the measure goes down) | 19 people | ||||
| IL-1Ra | Improves (the measure goes down) | 20 people | ||||
| Insulin | Changes; see studies | 77 people | ||||
| Interleukin 10 | Improves (the measure goes up) | 20 people | ||||
| Interleukin 6 | Improves (the measure goes down) | 34 people | ||||
| Leptin | Improves (the measure goes up) | 20 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 439 people | ||||
| Neutrophil Count | Improves (the measure goes up) | 34 people | ||||
| Plasma Vitamin E | Improves (the measure goes up) | 28 people | ||||
| Rating of Perceived Exertion | Improves (the measure goes up) | 34 people | ||||
| TNF-Alpha | Improves (the measure goes down) | 20 people | ||||
| Total cholesterol | Improves (the measure goes down) | 570 people | ||||
| Uric Acid | Improves (the measure goes down) | 19 people | ||||
| Weight | Improves (the measure goes down) | 84 people |
High Blood Pressure
- Adiponectin
- High-density lipoprotein (HDL): improves
- Blood Pressure: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Adiponectin No effect | NoneNo effect | 20 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 13 studies | 107 people | |||
| Blood Pressure | Improves (the measure goes down) | 10 studies | 1,772 people | |||
| Blood glucose | Improves (the measure goes down) | 5 studies | 60 people | |||
| Triglycerides | Improves (the measure goes down) | 3 studies | 79 people | |||
| Blood Flow | Improves (the measure goes up) | 2 studies | 100 people | |||
| Platelet Aggregation | Changes; see studies | 2 studies | 28 people | |||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 1 study | 87 people | |||
| Body Fat | Improves (the measure goes down) | 56 people | ||||
| Cell Adhesion Factors | Improves (the measure goes down) | 60 people | ||||
| Food Intake | Changes; see studies | 30 people | ||||
| Glycemic Control | Improves (the measure goes up) | 79 people | ||||
| Homocysteine | Improves (the measure goes down) | 19 people | ||||
| Insulin | Changes; see studies | 59 people | ||||
| Interleukin 6 | Improves (the measure goes down) | 20 people | ||||
| LDL Oxidation | Improves (the measure goes down) | 20 people | ||||
| Leptin | Improves (the measure goes up) | 20 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 107 people | ||||
| Muscle Mass | Improves (the measure goes up) | 20 people | ||||
| Nitric Oxide | Improves (the measure goes up) | 30 people | ||||
| TNF-Alpha | Improves (the measure goes down) | 40 people | ||||
| Total cholesterol | Improves (the measure goes down) | 79 people | ||||
| Uric Acid | Improves (the measure goes down) | 19 people | ||||
| Weight | Improves (the measure goes down) | 76 people |
Aerobic Exercise Performance
- Adrenocorticotropic Hormone
- Oxidative Stress Biomarkers: improves
- Fat Oxidation: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Adrenocorticotropic Hormone No effect | NoneNo effect | 20 people | ||||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 2 studies | 28 people | |||
| Fat Oxidation | Improves (the measure goes up) | 1 study | 20 people | |||
| Aerobic Exercise Metrics | Improves (the measure goes up) | 28 people | ||||
| Cortisol | Improves (the measure goes down) | 20 people | ||||
| Exercise-Induced Oxidation | Changes; see studies | 20 people | ||||
| Glucagon | Changes; see studies | 20 people | ||||
| Heart Rate | Improves (the measure goes down) | 20 people | ||||
| Insulin | Changes; see studies | 20 people | ||||
| Interleukin 10 | Improves (the measure goes up) | 20 people | ||||
| Interleukin 6 | Improves (the measure goes down) | 20 people | ||||
| Neutrophil Count | Improves (the measure goes up) | 20 people | ||||
| Plasma Vitamin E | Improves (the measure goes up) | 28 people | ||||
| Rating of Perceived Exertion | Improves (the measure goes up) | 20 people |
General Athletic Performance
- Adrenocorticotropic Hormone
- Blood Lactate (Exercise): changes; see studies
- Fat Oxidation: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Adrenocorticotropic Hormone No effect | NoneNo effect | 34 people | ||||
| Blood Lactate (Exercise) | Changes; see studies | 1 study | 14 people | |||
| Fat Oxidation | Improves (the measure goes up) | 1 study | 34 people | |||
| Anaerobic Capacity | Improves (the measure goes up) | 14 people | ||||
| Cortisol | Improves (the measure goes down) | 34 people | ||||
| Exercise-Induced Oxidation | Changes; see studies | 34 people | ||||
| Glucagon | Changes; see studies | 20 people | ||||
| Heart Rate | Improves (the measure goes down) | 34 people | ||||
| IL-1Ra | Improves (the measure goes down) | 20 people | ||||
| Insulin | Changes; see studies | 34 people | ||||
| Interleukin 10 | Improves (the measure goes up) | 20 people | ||||
| Interleukin 6 | Improves (the measure goes down) | 34 people | ||||
| Neutrophil Activity | Improves (the measure goes up) | 14 people | ||||
| Neutrophil Count | Improves (the measure goes up) | 34 people | ||||
| Rating of Perceived Exertion | Improves (the measure goes up) | 34 people |
Immune Health
- Adrenocorticotropic Hormone
- Fat Oxidation: improves
- Cortisol: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Adrenocorticotropic Hormone No effect | NoneNo effect | 14 people | ||||
| Fat Oxidation | Improves (the measure goes up) | 1 study | 14 people | |||
| Cortisol | Improves (the measure goes down) | 14 people | ||||
| Exercise-Induced Oxidation | Changes; see studies | 14 people | ||||
| Heart Rate | Improves (the measure goes down) | 14 people | ||||
| Insulin | Changes; see studies | 14 people | ||||
| Interleukin 6 | Improves (the measure goes down) | 14 people | ||||
| Neutrophil Activity | Improves (the measure goes up) | 14 people | ||||
| Neutrophil Count | Improves (the measure goes up) | 14 people |
Soccer Performance
- Aerobic Exercise Metrics
- Oxidative Stress Biomarkers: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Aerobic Exercise Metrics No effect | NoneNo effect | 28 people | ||||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 2 studies | 28 people |
General Gut Health
- Triglycerides: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Triglycerides | Improves (the measure goes down) | 3 studies | 22 people |
Acne
- Acne Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Acne Symptoms | Improves (the measure goes down) | 1 study | 13 people |
Chronic Kidney Disease (CKD)
- Kidney Oxygenation: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Kidney Oxygenation | Improves (the measure goes up) | 1 study | 10 people |
Key findings
- Blood FlowImproves (the measure goes up)
- Blood PressureImproves (the measure goes down)
- AdrenalineWorsens (the measure goes down)
Shop the evidence-backed picks
Third-party tested Cocoa Extract products, in the forms the graded studies used where we can match them.
- Grade B
Links to Fullscript, iHerb or Thorne carry our referral, so we may earn a commission at no extra cost to you. Grades come from the research and never change based on what we earn. Fullscript asks for a free account before it shows its catalog and prices. Full disclosure
Studies cited
56 studies from PubMed
- Effects of cocoa products/dark chocolate on serum lipids: a meta-analysis
- Regular consumption of a flavanol-rich chocolate can improve oxidant stress in young soccer players
- Effect of cocoa flavanols and exercise on cardiometabolic risk factors in overweight and obese subjects
- Short-term administration of dark chocolate is followed by a significant increase in insulin sensitivity and a decrease in blood pressure in healthy persons
- Cocoa consumption for 2 wk enhances insulin-mediated vasodilatation without improving blood pressure or insulin resistance in essential hypertension
- Blood pressure is reduced and insulin sensitivity increased in glucose-intolerant, hypertensive subjects after 15 days of consuming high-polyphenol dark chocolate
- The effect of polyphenol-rich dark chocolate on fasting capillary whole blood glucose, total cholesterol, blood pressure and glucocorticoids in healthy overweight and obese subjects
- Protective effects of flavanol-rich dark chocolate on endothelial function and wave reflection during acute hyperglycemia
- The effect of acute pre-exercise dark chocolate consumption on plasma antioxidant status, oxidative stress and immunoendocrine responses to prolonged exercise
- Prebiotic evaluation of cocoa-derived flavanols in healthy humans by using a randomized, controlled, double-blind, crossover intervention study
- Safety and efficacy of cocoa flavanol intake in healthy adults: a randomized, controlled, double-masked trial
- Regular dark chocolate consumption's reduction of oxidative stress and increase of free-fatty-acid mobilization in response to prolonged cycling
- Dark chocolate inhibits platelet isoprostanes via NOX2 down-regulation in smokers
- Influence of cocoa flavanols and procyanidins on free radical-induced human erythrocyte hemolysis
- Flavonoid-rich dark chocolate improves endothelial function and increases plasma epicatechin concentrations in healthy adults
- A double-blind, placebo-controlled, randomized trial of the effects of dark chocolate and cocoa on variables associated with neuropsychological functioning and cardiovascular health: clinical findings from a sample of healthy, cognitively intact older adults
- Dark chocolate effect on platelet activity, C-reactive protein and lipid profile: a pilot study
- Effects of dark chocolate and cocoa consumption on endothelial function and arterial stiffness in overweight adults
- Effects of Cocoa Consumption on Cardiometabolic Risk Markers: Meta-Analysis of Randomized Controlled Trials.
- Dark chocolate intake buffers stress reactivity in humans
- Effect of dark chocolate on arterial function in healthy individuals
- Dose-dependent increases in flow-mediated dilation following acute cocoa ingestion in healthy older adults
- Acute effect of oral flavonoid-rich dark chocolate intake on coronary circulation, as compared with non-flavonoid white chocolate, by transthoracic Doppler echocardiography in healthy adults
- Characterisation of hypertensive patients with improved endothelial function after dark chocolate consumption
- Blood pressure and endothelial function in healthy, pregnant women after acute and daily consumption of flavanol-rich chocolate: a pilot, randomized controlled trial
- Effect of dark chocolate on nitric oxide serum levels and blood pressure in prehypertension subjects
- NOX2-mediated arterial dysfunction in smokers: acute effect of dark chocolate
- Flavan-3-ol-enriched dark chocolate and white chocolate improve acute measures of platelet function in a gender-specific way--a randomized-controlled human intervention trial
- The effects of flavanol-rich cocoa and aspirin on ex vivo platelet function
- Sustained benefits in vascular function through flavanol-containing cocoa in medicated diabetic patients a double-masked, randomized, controlled trial
- Alterations in skeletal muscle indicators of mitochondrial structure and biogenesis in patients with type 2 diabetes and heart failure: effects of epicatechin rich cocoa
- Long-term ingestion of high flavanol cocoa provides photoprotection against UV-induced erythema and improves skin condition in women
- Chocolate flavanols and skin photoprotection: a parallel, double-blind, randomized clinical trial
- Cocoa Flavanol Supplementation Influences Skin Conditions of Photo-Aged Women: A 24-Week Double-Blind, Randomized, Controlled Trial
- Dark chocolate and vascular function in patients with peripheral artery disease: a randomized, controlled cross-over trial
- Dark chocolate acutely improves walking autonomy in patients with peripheral artery disease
- Cocoa reduces blood pressure and insulin resistance and improves endothelium-dependent vasodilation in hypertensives
- Consumption of high-polyphenol dark chocolate improves endothelial function in individuals with stage 1 hypertension and excess body weight
- Effect of cocoa on blood pressure
- Dark chocolate or tomato extract for prehypertension: a randomised controlled trial
- Dark chocolate for children's blood pressure: randomised trial
- Effect of cocoa products on blood pressure: systematic review and meta-analysis.
- Effects of dark chocolate consumption on the prothrombotic response to acute psychosocial stress in healthy men
- Effects of dark chocolate in a population of normal weight obese women: a pilot study
- Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: a systematic review and meta-analysis of randomized trials
- Chocolate consumption and cardiometabolic disorders: systematic review and meta-analysis.
- Relationship between chocolate consumption and overall and cause-specific mortality, systematic review and updated meta-analysis.
- The effect of flavanol-rich cocoa on the fMRI response to a cognitive task in healthy young people
- Cocoa polyphenols enhance positive mood states but not cognitive performance: a randomized, placebo-controlled trial
- Dark chocolate consumption improves leukocyte adhesion factors and vascular function in overweight men
- Effects of cocoa powder and dark chocolate on LDL oxidative susceptibility and prostaglandin concentrations in humans
- Postprandial effects of dark chocolate on portal hypertension in patients with cirrhosis: results of a phase 2, double-blind, randomized controlled trial
- The short-term effect of flavonoid-rich dark chocolate on retinal vessel diameter in glaucoma patients and age-matched controls
- Effect of dark chocolate on renal tissue oxygenation as measured by BOLD-MRI in healthy volunteers
- Double-blind, Placebo-controlled Study Assessing the Effect of Chocolate Consumption in Subjects with a History of Acne Vulgaris
- Chocolate Consumption and Risk of Heart Failure: A Meta-Analysis of Prospective Studies